Výsledky vyhledávání - "Edache S. Okpe"

Psychosocial Problems in Adolescents with Sickle Cell Anaemia on Hydroxyurea in Jos, North Central Nigeria

Autor: Daniel O. Aina, Ishaya I. Abok, Akinyemi O. D. Ofakunrin, Tolulope O. Afolaranmi, Olumide A. Ajayi, Lucius C. Imoh, Ayuba Affi, Olumide Olaniru, Bawa Abubakar, Christian O. Isichei, Edache S. Okpe

Publikováno v: East African Scholars Multidisciplinary Bulletin. 5:1-8

Background: A lot of adolescents with sickle cell anaemia constantly face unpleasant ill health conditions such as chronic pain as well as feelings of frustration over their general well-being and psychological adjustment which may distort medical ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::64f34fad51b2255c33f7e3e9d2d2e529
https://doi.org/10.36349/easjmb.2022.v05i01.001

Zobrazit plný text záznamu

Level of utilization and provider-related barriers to the use of hydroxyurea in the treatment of sickle cell disease patients in Jos, North-Central Nigeria

Autor: Patience U. Kanhu, Akinyemi O. D. Ofakunrin, Rasaq Olaosebikan, Edache S. Okpe, Nantok Dami, Kehinde Adekola, Tolulope O Afolaranmi, Atiene S. Sagay

Publikováno v: African Health Sciences

Background: Hydroxyurea is underutilized by sickle cell health-care providers in Nigeria despite available evidence of its effectiveness in reducing the manifestations and complications of sickle cell disease (SCD). Objectives: To assess the level of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ced1447513d721156fffedfdb87fb7
https://pubmed.ncbi.nlm.nih.gov/34795734

Zobrazit plný text záznamu

Effectiveness and Safety of Hydroxyurea in the Treatment of Sickle Cell Anaemia Children in Jos, North Central Nigeria

Autor: Stephen Oguche, Edache S. Okpe, Ijeoma N. Diaku-Akinwumi, Kehinde Adekola, Atiene S. Sagay, Akinyemi Olugbenga David Ofakunrin, Tolulope O Afolaranmi, Ayuba Ibrahim Zoakah

Publikováno v: Journal of Tropical Pediatrics

Background Hydroxyurea has been shown to positively modify sickle cell disease pathogenesis, but its use is low among Nigerian sickle cell anaemia (SCA) patients because of effectiveness and safety concerns. Methods We conducted a quasi-experimental

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfab0430da15386532d7aa1fa863a1ec
http://europepmc.org/articles/PMC7249733

Zobrazit plný text záznamu

Prevalence and Pattern of Non-communicable Diseases in Children in Jos, Nigeria

Autor: Akinyemi O. D. Ofakunrin, Helen O. Akhiwu, Idris A. Adedeji, Emeka U. Ejeliogu, Esther S. Yiltok, Edache S. Okpe

Publikováno v: British Journal of Medicine and Medical Research. 19:1-7

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::05ba4fa21d6b8549973fb60275429403
https://doi.org/10.9734/bjmmr/2017/30410

Zobrazit plný text záznamu

Sero-negative Antibody Status in HIV-Infected Children Initiated on Early Anti-Retroviral Therapy in Jos, Nigeria

Autor: Edache S. Okpe, Prosper Okonkwo, Stephen Oguche, Oche Agbaji, M. O. Ochoga, Collins John, Esther S. Yiltok, Augustine O. Ebonyi

Publikováno v: British Journal of Medicine and Medical Research. 4:4892-4900

Aim: To determine the association between the age at initiation of anti-retroviral therapy (ART) and the 18 month antibody status of human immunodeficiency virus (HIV)-infected children in Jos, Nigeria. Study Design: This was a retrospective cohort s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::62bfe1403afe8e9c79f18e254a49397b
https://doi.org/10.9734/bjmmr/2014/10951

Zobrazit plný text záznamu

Level of Utilization and Provider-Related Barriers to Hydroxyurea Use in the Treatment of Sickle Cell Disease in Jos, Nigeria

Autor: Patience U. Kanhu, Atiene S. Sagay, Akinyemi Olugbenga David Ofakunrin, Stephen Oguche, Kehinde Adekola, Edache S. Okpe, Tolulope O Afolaranmi, Nantok Dami

Publikováno v: Blood. 134:1029-1029

Background: Hydroxyurea is one of the currently approved medications capable of modifying the pathogenesis of sickle cell disease (SCD), and its use has transformed the management of this disease worldwide.However, available evidences suggest that hy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::914f41c795b5e213dc10be2fd71b6cbf
https://doi.org/10.1182/blood-2019-128185

Zobrazit plný text záznamu

Efficacy and Safety of Hydroxyurea in the Treatment of Sickle Cell Anemia Children in Jos, North Central Nigeria

Autor: Stephen Oguche, Atiene S. Sagay, Kehinde Adekola, Edache S. Okpe, Akinyemi Olugbenga David Ofakunrin

Publikováno v: Blood. 132:1081-1081

Introduction: Sickle Cell Anaemia (SCA) is a genetic disorder with significant morbidity and mortality, and Nigeria accounts for the highest burden of the disease worldwide. Hydroxyurea has been shown to positively modify the disease pathogenesis, bu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a972066c99fde827b40d051dd2d31681
https://doi.org/10.1182/blood-2018-99-115598

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání